Global Pharmaceuticals & Biotech Big Green Snowflakes

Ocular Therapeutix

Market Cap: US$2.2b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

Contineum Therapeutics

Market Cap: US$351.1m

A clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications with high unmet need in the United States.

Bafna Pharmaceuticals

Market Cap: ₹2.5b

Manufactures and sells finished pharmaceutical formulations in India.

Walvax Biotechnology

Market Cap: CN¥19.6b

Engages in the research and development, manufacture, and distribution of vaccines in China.

Enwei Pharmaceutical

Market Cap: CN¥3.4b

Develops and sells Chinese medicines in China.

Syngene International

Market Cap: ₹259.8b

A contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.

Windlas Biotech

Market Cap: ₹20.7b

A contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India.

SoftOx Solutions

Market Cap: NOK 213.4m

Operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.

Shandong Boan Biotechnology

Market Cap: HK$8.1b

A biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China.

Jin Yang Pharmaceutical

Market Cap: ₩69.8b

Engages in the pharmaceutical business in South Korea.

Guiyang Xintian PharmaceuticalLtd

Market Cap: CN¥2.7b

Engages in the research and development, production, and sale of new Chinese patent medicines in China.

Ovoca Bio

Market Cap: UK£938.0k

A clinical-stage biopharmaceutical company, develops and commercializes novel product candidates for women health.

Cai Lay Veterinary Pharmaceutical

Market Cap: ₫47.5b

Manufactures and supplies veterinary pharmaceutical products in Vietnam and Indochina.

Rhythm Pharmaceuticals

Market Cap: US$6.7b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

Biodexa Pharmaceuticals

Market Cap: US$3.5m

A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.

GRI Bio

Market Cap: US$3.9m

A clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States.

Biogened

Market Cap: zł59.9m

Develops, produces, and distributes pharmaceutical products in Poland.

Incanthera

Market Cap: UK£4.5m

A dermatology and oncology therapeutics company, focuses on the dermatological formulation and delivery technologies for various indications.

Quoin Pharmaceuticals

Market Cap: US$4.3m

A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.

Anavex Life Sciences

Market Cap: US$881.3m

Operates as a biopharmaceutical company.

Candel Therapeutics

Market Cap: US$272.8m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

Bio-Rad Laboratories

Market Cap: US$7.5b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Cognition Therapeutics

Market Cap: US$223.2m

A clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.

Bolt Biotherapeutics

Market Cap: US$9.7m

A clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer.

Adaptimmune Therapeutics

Market Cap: US$13.0m

A commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.

Akanda

Market Cap: US$2.4m

Through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products.

Ligand Pharmaceuticals

Market Cap: US$3.2b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Oculis Holding

Market Cap: US$899.7m

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.

Inhibikase Therapeutics

Market Cap: US$124.4m

Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.

Titan Pharmaceuticals

Market Cap: US$5.4m

Does not have significant operations.

Collegium Pharmaceutical

Market Cap: US$1.2b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Oruka Therapeutics

Market Cap: US$601.1m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Repligen

Market Cap: US$6.7b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

PMV Pharmaceuticals

Market Cap: US$84.8m

A precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer.

Perspective Therapeutics

Market Cap: US$250.3m

Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.

Equillium

Market Cap: US$108.9m

A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States.